Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib
Clinical trial NCT06341621 · RECRUITING
Trial details
- NCT number
- NCT06341621
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-02
- Primary completion
- 2027-02-25
- Enrollment
- 1900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.